For the Quarter Ending March 2026
Ciprofloxacin HCL Prices in North America
- In United States, the Ciprofloxacin HCL Price Index rose quarter-over-quarter in Q1 2026, driven by surging precursor costs.
- In March 2026, CPI rose 3.3% and PPI climbed 4.0%, pushing the Ciprofloxacin HCL Production Cost Trend upward.
- Retail sales grew 4.0% and unemployment stabilized at 4.3% in March 2026, supporting the Ciprofloxacin HCL Demand Outlook.
- Industrial production grew 0.7% and consumer confidence reached 91.8 in March 2026, elevating the Ciprofloxacin HCL Price Forecast.
- The Manufacturing Index expanded in March 2026, ensuring steady production throughput for the Ciprofloxacin HCL market.
- Naphtha feedstock and aromatic precursor costs surged in Q1 2026 due to severe Middle East supply disruptions.
- Drug shortages decreased in February 2026, stabilizing downstream demand for active pharmaceutical ingredients like Ciprofloxacin HCL.
- Restructured US tariffs on imported active pharmaceutical ingredients in February 2026 altered Ciprofloxacin HCL trade dynamics.
- US natural gas production increased in January 2026, providing energy buffers for Ciprofloxacin HCL manufacturing facilities.
Why did the price of Ciprofloxacin HCL change in March 2026 in North America?
- Naphtha feedstock costs surged in Q1 2026 due to severe Middle East export supply disruptions.
- Producer prices climbed 4.0% in March 2026, forcing manufacturers to pass elevated costs to buyers.
- Restructured US tariffs on imported active pharmaceutical ingredients in February 2026 altered international trade dynamics.
Ciprofloxacin HCL Prices in APAC
- In China, the Ciprofloxacin HCL Price Index rose quarter-over-quarter in Q1 2026, driven by surging hospital demand.
- The Ciprofloxacin HCL Production Cost Trend increased in March 2026 as the Producer Price Index rose 0.5%.
- The Ciprofloxacin HCL Demand Outlook strengthened in January 2026 due to rising hospital admissions for bacterial infections.
- A 1.0% Consumer Price Index increase and 5.7% industrial production growth in March 2026 supported Ciprofloxacin HCL.
- The Manufacturing Index expanded in March 2026, reflecting robust industrial activity and steady Ciprofloxacin HCL API procurement.
- Slower retail sales of 1.7% and 5.4% unemployment in March 2026 slightly dampened veterinary Ciprofloxacin HCL demand.
- Low consumer confidence at 91.6 in February 2026 indicated cautious spending, limiting downstream Ciprofloxacin HCL volume growth.
- The Ciprofloxacin HCL Price Forecast remained elevated in March 2026 as domestic liquefied natural gas prices surged.
Why did the price of Ciprofloxacin HCL change in March 2026 in APAC?
- Hospital sector demand for intravenous Ciprofloxacin HCL formulations surged in March 2026, pushing market prices upward.
- Manufacturing expenses for chemical intermediates increased in March 2026 amid stringent environmental regulations and compliance costs.
- Export volumes of generic fluoroquinolone formulations from China strengthened in March 2026, tightening domestic market availability.
Ciprofloxacin HCL Prices in Europe
- In Germany, the Ciprofloxacin HCL Price Index rose quarter-over-quarter in Q1 2026, driven by surging energy feedstock costs.
- The Ciprofloxacin HCL Production Cost Trend increased significantly in March 2026 as national inflation reached 2.7 percent.
- Despite the rising Ciprofloxacin HCL Price Index, industrial producer prices reached -0.2 percent during March 2026.
- The Ciprofloxacin HCL Demand Outlook stabilized as the national Manufacturing Index expanded steadily during March 2026.
- Industrial production remained stagnant at 0.0 percent in February 2026, reflecting flat Ciprofloxacin HCL pharmaceutical processing activity.
- Retail sales grew 0.7 percent and unemployment stayed at 4.2 percent in February 2026, supporting baseline consumption.
- The Ciprofloxacin HCL Price Forecast incorporated a negative 24.7 consumer confidence index recorded during March 2026.
- Global supply chains for essential Ciprofloxacin HCL chemical intermediates faced severe logistical disruptions throughout Q1 2026.
- European natural gas prices, the primary energy source for Ciprofloxacin HCL precursors, surged sharply in March 2026.
Why did the price of Ciprofloxacin HCL change in March 2026 in Europe?
- Natural gas feedstock costs for Ciprofloxacin HCL precursors surged significantly in Europe during March 2026.
- The European supply of ammonia, a critical Ciprofloxacin HCL precursor, tightened considerably throughout Q1 2026.
- Middle East trade flows for chemical intermediates used in Ciprofloxacin HCL disrupted during Q1 2026.
For the Quarter Ending December 2025
Ciprofloxacin HCL Prices in North America
- In United States, the Ciprofloxacin HCL Price Index rose quarter-over-quarter in Q4 2025, driven by increasing production costs.
- Ciprofloxacin HCL production costs increased, influenced by a 3.0% PPI rise in November 2025, impacting intermediate chemicals.
- Demand outlook remained stable in Q4 2025, supported by a 4.4% unemployment rate in December 2025, aiding healthcare access.
- The Ciprofloxacin HCL Price Index experienced upward pressure from a 2.7% CPI increase in December 2025, affecting raw materials.
- Natural gas spot prices strengthened in Q4 2025, contributing to higher energy and feedstock expenses for manufacturers.
- Industrial production increased by 2.0% year-over-year in December 2025, indicating a supportive economic environment.
- Retail sales rose by 3.3% year-over-year in November 2025, bolstering consumer capacity for healthcare spending.
- Global oversupply of petrochemicals persisted in 2025, influencing broader chemical market dynamics and trade flows.
Why did the price of Ciprofloxacin HCL change in December 2025 in North America?
- Ciprofloxacin HCL production costs increased from a 3.0% PPI rise in November 2025.
- General inflation, a 2.7% CPI increase in December 2025, raised raw material expenses.
- Strengthening natural gas spot prices in Q4 2025 contributed to higher energy inputs.
Ciprofloxacin HCL Prices in APAC
- In China, the Ciprofloxacin HCL Price Index fell quarter-over-quarter in Q4 2025, driven by weak consumer demand and producer deflation.
- Ciprofloxacin HCL production costs faced moderate upward pressure from glacial acetic acid and volatile methanol prices in Q4 2025.
- Ciprofloxacin HCL demand outlook was challenged by decelerated economic growth and soft domestic consumption in Q4 2025.
- China's industrial production expanded by 5.2% in December 2025, supporting API demand.
- China's Manufacturing Index expanded in December 2025, indicating industrial sector growth.
- Oversupply in China's domestic petrochemical markets in November 2025 contributed to a challenging pricing environment.
- China's medicine exports steadily increased in the first 11 months of 2025, despite global trade disruptions.
- The pharmaceutical market in China experienced rapid growth throughout 2025, indicating underlying sector strength.
- Industrial profits rebounded in December 2025, reversing a fall in November, signaling improving manufacturing conditions.
Why did the price of Ciprofloxacin HCL change in December 2025 in APAC?
- Weak consumer demand, with CPI at 0.8% and retail sales growth at 0.9% in December 2025, limited pricing power.
- Producer deflation, as PPI fell by 1.9% in December 2025, indicated weak industrial demand and pricing.
- Oversupply in China's domestic petrochemical markets in November 2025 contributed to a challenging pricing environment.
Ciprofloxacin HCL Prices in Europe
- In Germany, the Ciprofloxacin HCL Price Index remained stable in Q4 2025, influenced by contained CPI at 1.8% in December 2025.
- Ciprofloxacin HCL production costs increased during October-December 2025 due to elevated energy and raw material expenses.
- The Ciprofloxacin HCL Demand Outlook was supported by an increase in pharmaceuticals output in Germany in 2025.
- The Manufacturing Index showed a contracting trend in December 2025, indicating a slowdown in industrial activity.
- Producer prices for industrial products declined by 2.5% year-over-year in December 2025, reducing some input costs.
- Consumer confidence significantly declined to -17.5 in December 2025, reflecting broader economic pessimism.
- Industrial production grew modestly by 0.8% in October 2025, while retail sales increased by 1.1% in November 2025.
- The unemployment rate stood at 6.2% in December 2025, suggesting a stable labor pool and predictable wage costs.
- The Ciprofloxacin HCL Price Forecast suggests continued stability, balancing cost pressures and demand in Q4 2025.
Why did the price of Ciprofloxacin HCL change in December 2025 in Europe?
- Producer prices for industrial products declined by 2.5% year-over-year in December 2025, easing manufacturing input costs.
- Elevated energy and raw material costs in October 2025 pressured Ciprofloxacin HCL production expenses.
- Consumer confidence declined significantly to -17.5 in December 2025, reflecting broader economic caution.
For the Quarter Ending September 2025
Ciprofloxacin HCL Prices in North America
- In the United States, the Ciprofloxacin HCL Price Index rose quarter-over-quarter in Q3 2025, driven by costs and demand.
- Production costs increased from 2.6% YoY PPI in August 2025 and 3.0% YoY CPI in September 2025.
- Tariffs significantly raised chemical input costs in Q3 2025, compressing manufacturer margins.
- Demand was supported by robustly increased pharmaceutical market catalyst activity during Q3 2025.
- Strong consumer spending, retail sales up 5.42% YoY in September 2025, bolstered healthcare.
- Low unemployment, 4.3% in September 2025, supported patient access to healthcare and prescriptions.
- Weak industrial production, up 0.1% YoY in September 2025, indicated economic sluggishness.
- Declining consumer confidence (94.2 in Sep 2025) suggested cautious spending, impacting healthcare.
- Chemical inventories shrank in Q3 2025 as destocking efforts impacted Ciprofloxacin HCL supply.
- The Ciprofloxacin HCL price forecast suggests continued upward pressure from accelerating production costs after Q3 2025.
Why did the price of Ciprofloxacin HCL change in September 2025 in North America?
- Rising producer prices (2.6% YoY Aug 2025) increased Ciprofloxacin HCL manufacturing costs.
- Tariffs significantly raised chemical input costs in Q3 2025, compressing margins.
- Robust pharmaceutical market activity and drug approvals in Q3 2025 boosted demand.
Ciprofloxacin HCL Prices in APAC
- In China, the Ciprofloxacin HCL Price Index fell quarter-over-quarter in Q3 2025, influenced by declining factory-gate prices.
- China's Producer Price Index (PPI) declined -2.3% year-on-year in September 2025, indicating reduced production costs.
- Consumer Price Index (CPI) decreased -0.3% year-on-year in September 2025, reflecting deflationary pressures.
- The Manufacturing Index was contracting in September 2025, signaling a slowdown in industrial activity.
- Industrial production increased 6.5% year-on-year in September 2025, supporting stable pharmaceutical supply chains.
- Production costs faced upward pressure from strengthening natural gas and surging coal prices in Q3 2025.
- Overall chemical inventories remained elevated in Q3 2025 due to persistent overcapacity in China.
- Demand for Ciprofloxacin HCL was bolstered by an aging population and rising healthcare needs in Q3 2025.
- Retail sales grew 3.0% year-on-year in September 2025, indicating stable consumer demand.
Why did the price of Ciprofloxacin HCL change in September 2025 in APAC?
- Declining factory-gate prices, with PPI falling -2.3% year-on-year in September 2025, reduced cost pass-through.
- A contracting Manufacturing Index in September 2025 indicated a general slowdown, dampening market sentiment.
- Elevated chemical inventories in Q3 2025, driven by overcapacity, exerted downward pressure.
Ciprofloxacin HCL Prices in Europe
- In Germany, the Ciprofloxacin HCL Price Index rose in Q3 2025, influenced by elevated production costs and strengthening demand.
- Ciprofloxacin HCL production costs increased in Q3 2025, driven by persistently elevated energy costs.
- Demand for Ciprofloxacin HCL strengthened in Q3 2025 due to rising bacterial infections and awareness.
- The Manufacturing Index trended contracting in September 2025, reflecting a slowdown in German industrial activity.
- Germany's industrial production declined by 1.0% year-over-year in September 2025, impacting supply chain stability.
- Consumer Price Index (CPI) rose by 2.4% year-over-year in September 2025, signaling higher operational costs.
- Producer Price Index (PPI) declined by 1.7% year-over-year in September 2025, suggesting moderation in raw material costs.
- German pharmaceutical market growth remained sustained in 2025, underpinned by an aging population and chronic diseases.
- German imports of pharmaceutical products increased in Q3 2025, while exports of goods slightly declined.
Why did the price of Ciprofloxacin HCL change in September 2025 in Europe?
- Elevated energy costs in Germany during Q3 2025 significantly increased Ciprofloxacin HCL production expenses.
- Strengthening demand for antibiotics in Q3 2025 exerted upward Ciprofloxacin HCL price pressure.
- A 2.4% CPI increase in September 2025 raised Ciprofloxacin HCL manufacturers' operational costs.
For the Quarter Ending December 2022
North America
The Ciprofloxacin Hydrochloride market began in the last quarter of 2022 on a positive note in North American due to growing demand from the end-user pharmaceutical industry, with its prices soaring to USD 35570/MT in October. Doxycycline Hydrochloride was mainly imported from China; however, the long week holiday and zero-covid regulation affected its importing activities to overseas countries.
However, prices dropped in November as retailers in the country had enough inventory to meet all downstream demand due to a resume in trade and purchasing activities. Also, suppliers reduced the price of their products by 14.7% in December 2022 due to the gloomy market dynamics. However, by the end of the quarter, the prices for Ciprofloxacin Hydrochloride settled at USD 30500/MT.
Asia- Pacific
In the fourth quarter of 2022, the price trend for Ciprofloxacin Hydrochloride in the Asia Pacific area began to decline. In China, the Golden Week vacation around the first week of October affected the manufacturing activity of plants, but it had a lower impact on inventories as orders were only coming for urgent use from both local and foreign purchasers. The domestic producers and suppliers were able to satisfy the demand due to the adequate amount of stocks on hand. Even after the vacations, some manufacturers opted to lower their operational rates due to the fallen demand from the downstream pharmaceutical industries backed by the epidemic's consequences. However, FOB Shanghai prices for Ciprofloxacin Hydrochloride moved to USD 24120/MT in December from USD 26800/MT in October.
Europe
The European market witnessed mixed sentiments in Ciprofloxacin Hydrochloride prices during the fourth quarter of 2022 due to the fluctuating downstream demand from various pharmaceutical industries. At the onset of Q4, the prices for Ciprofloxacin Hydrochloride went up significantly owing to consistent purchasing from domestic buyers. Also, the local market faced a shortage of inventories due to a long break in the supply chain from Asian nations, notably China. However, from mid-Q4, the prices started to decrease due to dull market sentiments on the back of slow demand from downstream pharmaceutical and healthcare industries. Additionally, high stock levels forced dealers to lower prices in order to empty their vast inventories deliberately. Therefore, CFR Hamburg prices of Ciprofloxacin Hydrochloride in Germany shifted from USD 35570/MT to USD 30500/MT from October to December 2022.
